1.37069
pDADMAC solution 10%
EMPROVE® EVOLVE, Flocculation reagent
Select a Size
About This Item
Skip To
Product Name
pDADMAC solution 10%, EMPROVE® EVOLVE, Flocculation reagent
product line
EMPROVE® EVOLVE
form
liquid
pH
7.8 ( in H2O, ready-to-use solution)
density
1.015 g/cm3
storage temp.
15-25°C
Quality Level
1 of 4
This Item | HT501850 | HT501640 | 4.80905 |
|---|---|---|---|
| form liquid | form - | form - | form liquid |
| pH 7.8 ( in H2O, ready-to-use solution) | pH 6.90-7.10 | pH 6.90-7.10 | pH - |
| density 1.015 g/cm3 | density 1.080 g/cm3 | density 1.080 g/cm3 | density 0.957 g/cm3 at 20 °C |
| storage temp. 15-25°C | storage temp. room temp | storage temp. room temp | storage temp. 2-25°C |
| Quality Level 400 | Quality Level 200 | Quality Level 200 | Quality Level 500 |
Legal Information
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Stay compliant with GMP using the Emprove® Program
Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.
Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.
Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite
Not finding what you are looking for? Visit the Emprove® Program Help page.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Related Content
Learn more on mAb downstream processing, more specifically clarification and the relevant associated products.
Flocculants, like pDADMAC, remove cell debris during downstream monoclonal antibody production, but their adoption has been difficult due to perceived regulatory concerns.
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service